We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $38.4B
1-Year Est. Return 25.71%
This Fund
S&P 500
This Quarter Est. Return
+13.98%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$27.3B
AUM Growth
+$3.7B
Cap. Flow
+$865M
Cap. Flow %
3.17%
Top 10 Hldgs %
25.38%
Holding
1,900
New
178
Increased
749
Reduced
623
Closed
72

Sector Composition

Rank Sector Weight
1 Technology 27.82%
2 Healthcare 18.6%
3 Financials 11.15%
4 Consumer Discretionary 10.38%
5 Industrials 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRC
1026
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$609K ﹤0.01%
+6,220
New +$581K
IR icon
1027
Ingersoll Rand
IR
$32.7B
$606K ﹤0.01%
13,304
-102
-0.8% -$4.22K
REGN icon
1028
Regeneron Pharmaceuticals
REGN
$83B
$604K ﹤0.01%
1,251
-270
-18% -$146K
THFF icon
1029
First Financial Corp
THFF
$975M
$600K ﹤0.01%
15,454
ITGR icon
1030
Integer Holdings
ITGR
$4.25B
$599K ﹤0.01%
7,383
-149
-2% -$10.5K
SCHB icon
1031
Schwab US Broad Market ETF
SCHB
$45.2B
$599K ﹤0.01%
39,498
-2,682
-6% -$38.2K
MCY icon
1032
Mercury Insurance
MCY
$5.81B
$597K ﹤0.01%
11,437
-900
-7% -$40.2K
FBIN icon
1033
Fortune Brands Innovations
FBIN
$5.78B
$588K ﹤0.01%
8,029
-324
-4% -$23.6K
DELL icon
1034
Dell
DELL
$320B
$586K ﹤0.01%
15,776
-462
-3% -$16.1K
NI icon
1035
NiSource
NI
$20.2B
$585K ﹤0.01%
25,500
+13
+0.1% +$304
BWIN
1036
Baldwin Insurance Group
BWIN
$2.99B
$584K ﹤0.01%
+19,470
New +$563K
RVNC
1037
DELISTED
Revance Therapeutics, Inc.
RVNC
$580K ﹤0.01%
20,481
+9,640
+89% +$250K
GEN icon
1038
Gen Digital
GEN
$17.7B
$579K ﹤0.01%
27,887
+690
+3% +$13.9K
SOXX icon
1039
iShares Semiconductor ETF
SOXX
$46.6B
$578K ﹤0.01%
+4,572
New +$525K
CRNC icon
1040
Cerence
CRNC
$389M
$577K ﹤0.01%
5,745
+730
+15% +$54.4K
MGEE icon
1041
MGE Energy Inc
MGEE
$3.06B
$577K ﹤0.01%
8,238
-115
-1% -$7.93K
PEG icon
1042
Public Service Enterprise Group
PEG
$37.8B
$576K ﹤0.01%
9,875
+991
+11% +$57.7K
VGIT icon
1043
Vanguard Intermediate-Term Treasury ETF
VGIT
$42.5B
$576K ﹤0.01%
8,302
-378
-4% -$26.4K
SPOK icon
1044
Spok Holdings
SPOK
$230M
$566K ﹤0.01%
+50,865
New +$502K
IYH icon
1045
iShares US Healthcare ETF
IYH
$3.77B
$564K ﹤0.01%
11,470
-790
-6% -$37.3K
DXYN
1046
DELISTED
Dixie Group Inc
DXYN
$564K ﹤0.01%
221,255
GRMN
1047
Garmin
GRMN
$60.2B
$562K ﹤0.01%
4,695
-9,103
-66% -$1.01M
XIFR
1048
XPLR Infrastructure LP
XIFR
$1.09B
$562K ﹤0.01%
8,377
+1,697
+25% +$109K
AMJ
1049
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$562K ﹤0.01%
40,493
+7,120
+21% +$92.6K
SH icon
1050
ProShares Short S&P500
SH
$839M
$560K ﹤0.01%
7,792
-2,612
-25% -$200K

Similar funds

William Blair & Company's Q4 2020 Portfolio in Review

As of Q4 2020, William Blair & Company held 1,900 positions worth $27.3B, up 16% from $23.6B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

William Blair & Company deployed $865M of net new capital in Q4 2020, opening 178 new positions and adding to 749 existing holdings. Its largest new stake was Seagen Inc. Common Stock: 91,539 shares worth $16M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Slack Technologies, Inc., an estimated $24.2M trimmed.

  • William Blair & Company's largest Q4 2020 buy was Seagen Inc. Common Stock: 91,539 shares worth $16M.
  • William Blair & Company added most to Splunk Inc in Q4 2020, an estimated $77.8M increase.
  • William Blair & Company's biggest Q4 2020 reduction was Slack Technologies, Inc., cutting an estimated $24.2M.
  • William Blair & Company fully exited Dunkin' Brands Group, Inc. in Q4 2020, selling an estimated $12.1M.
  • William Blair & Company's ten largest holdings make up 25% of its $27.3B portfolio in Q4 2020.
  • William Blair & Company opened 178 new positions and closed 72 in Q4 2020.
  • William Blair & Company's portfolio value rose 16% quarter-over-quarter to $27.3B.

Based on William Blair & Company's 13F filing for Q4 2020, filed 9 Feb 2021.